Key result
Inhibiting miR-155-5p limits hypoxic cardiomyocyte pyroptosis via SIRT1-mediated NLRP3 suppression.
Why the study?
Hypoxia/reoxygenation-induced pyroptosis of cardiomyocytes plays a crucial role in myocardial infarction, but the involvement of miR-155-5p in this process remained unclear.
Does inhibition of miR-155-5p reduce pyroptosis in hypoxia/reoxygenation-exposed rat cardiomyocytes?
Does inhibition of miR-155-5p reduce pyroptosis in hypoxia/reoxygenation-exposed rat cardiomyocytes?
Inhibition of miR-155-5p protects cardiomyocytes from hypoxia/reoxygenation-induced pyroptosis by targeting SIRT1 and suppressing the NLRP3 inflammasome, suggesting a potential therapeutic mechanism for myocardial ischemia/reperfusion injury.
miR-155-5p inhibition merits further in vivo validation in myocardial I/R models; hypothesis-generating and should not yet change practice.
OBJECTIVE: The hypoxia/reoxygenation (H/R)-induced pyroptosis of cardiomyocytes plays a crucial role in the pathogenesis of myocardial infarction (MI). miR-155-5p represents a promising target for MI therapy. However, its involvement in H/R-induced pyroptosis remains unclear. METHODS: The H/R exposed rat cardiomyocyte H9c2 was utilized as in vitro model, and the expression levels of miR-155-5p and SIRT1 in cells were modulated through cell transfection experiments. Cell proliferative activity was assessed using the Cell counting kit-8 assay. Supernatant lactate dehydrogenase (LDH) activity was determined through colorimetry. The levels of living and dead cell were observed via Calcin-AM/PI staining. Levels of supernatant interleukin (IL)-1β and IL-18 were measured using ELISA assay. The expression levels of miR-155-5p and silent information regulator 1 (SIRT1) mRNA were detected by qRT-PCR. The protein expression levels of SIRT1, NLRP3, N-terminal gasdermin D (GSDMD-N), and Cleaved caspase-1 were evaluated using Western blot analysis. The targeted regulatory relationship between miR-155-5p and SIRT1 was verified using dual luciferase reporter gene assay. RESULTS: The proliferation activity of H9c2 cells induced by H/R was attenuated, accompanied by severe injury, increased cell death, and the release of a substantial amount of pro-inflammatory cytokines IL-1β and IL-18. In addition, H/R stimulation resulted in the upregulation of miR-155-5p expression and downregulation of SIRT1 expression in H9c2 cells. Suppression of miR-155-5p or overexpression of SIRT1 exhibited ameliorative effects on H/R-induced cellular injury in H9c2 cells and inhibited NLRP3 inflammasome-mediated pyroptosis. The dual-luciferase assay confirmed the direct targeting of SIRT1 by miR-155-5p in H9c2 cells. Furthermore, partial reversal of the inhibitory effect of miR-155-5p inhibitor on H/R-induced NLRP3 inflammasome-mediated pyroptosis in H9c2 cells was observed upon interference with SIRT1 expression. CONCLUSION: Inhibition of miR-155-5p alleviates cardiomyocyte pyroptosis induced by H/R via targeting SIRT1-mediated activation of the NLRP3 inflammasome.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied Myocardial infarction (in vitro hypoxia/reoxygenation model). miR-155-5p inhibitor and SIRT1 overexpression vs. Negative control (inhibitor-NC) and empty carrier plasmid was evaluated on Cardiomyocyte pyroptosis and cellular injury (LDH release, cell death, IL-1β and IL-18 levels). Inhibition of miR-155-5p alleviated hypoxia/reoxygenation-induced cardiomyocyte pyroptosis and cellular injury by targeting SIRT1-mediated activation of the NLRP3 inflammasome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: